Search results for "Receptor"

showing 10 items of 6990 documents

A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiog…

2021

Dopamine receptor 2 agonists (D2-ags) have been shown to reduce the size of tumors by targeting aberrant angiogenesis in pathological tissue. Because of this, the use of a D2-ag was inferred for endometriosis treatment. When assayed in mouse models however, D2-ags have been shown to cause a shift of the immature vessels towards a more mature phenotype but not a significant reduction in the amount of vascularization and size of lesions. These has raised concerns on whether the antiangiogenic effects of these compounds confer a therapeutic value for endometriosis. In the belief that antiangiogenic effects of D2-ags in endometriosis were masked due to non-optimal timing of pharmacological inte…

endometriosis0301 basic medicineAgonistAngiogenesismedicine.drug_classEndometriosisdopamine agonistMedicine (miscellaneous)Dopamine agonistArticleGeneral Biochemistry Genetics and Molecular BiologyLesion03 medical and health sciencesheterologous mouse model0302 clinical medicineIn vivoCabergolinemedicinelcsh:QH301-705.5030219 obstetrics & reproductive medicinebusiness.industryantiangiogenicmedicine.disease030104 developmental biologylcsh:Biology (General)anti-VEGFDopamine receptorCancer researchmedicine.symptombusinessmedicine.drugBiomedicines
researchProduct

Estrogen Receptor and Vascular Aging.

2021

Cardiovascular diseases remain an age-related pathology in both men and women. These pathologies are 3-fold more frequent in men than in women before menopause, although this difference progressively decreases after menopause. The vasculoprotective role of estrogens are well established before menopause, but the consequences of their abrupt decline on the cardiovascular risk at menopause remain debated. In this review, we will attempt to summarize the main clinical and experimental studies reporting the protective effects of estrogens against cardiovascular diseases, with a particular focus on atherosclerosis, and the impact of aging and estrogen deprivation on their endothelial actions. Th…

endotheliumvascular agingGeriatricsestradiolRC952-954.6menopauseGeneral Medicineatherosclerosisestrogen receptorFrontiers in aging
researchProduct

GABA and its receptors in the enteric nervous system of the gastrointestinal tract.

2009

enteric nerous systems GABA receptors intestinal motilitySettore BIO/09 - Fisiologia
researchProduct

Echovirus 1 internalization negatively regulates epidermal growth factor receptor downregulation

2017

We have demonstrated previously that the human picornavirus Echovirus 1 (EV1) triggers an infectious internalization pathway that follows closely, but seems to stay separate, from the epidermal growth factor receptor (EGFR) pathway triggered by epidermal growth factor (EGF). Here, we confirmed by using live and confocal microscopy that EGFR and EV1 vesicles are following intimately each other but are distinct entities with different degradation kinetics. We show here that despite being sorted to different pathways and located in distinct endosomes, EV1 inhibits EGFR downregulation. Simultaneous treatment with EV1 and EGF led to an accumulation of EGFR in cytoplasmic endosomes, which was evi…

enterovirussignalingendosytoosiepidermal growth factor receptor (EGFR)pilaantuminen
researchProduct

SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus.

2006

Histone acetylation plays a key role in the regulation of gene expression. The chromatin structure and accessibility of genes to transcription factors is regulated by enzymes that acetylate and deacetylate histones. The Sin3A corepressor complex recruits histone deacetylases and in many cases represses transcription. Here, we report that SAP30L, a close homolog of Sin3-associated protein 30 (SAP30), interacts with several components of the Sin3A corepressor complex. We show that it binds to the PAH3/HID (Paired Amphipathic Helix 3/Histone deacetylase Interacting Domain) region of mouse Sin3A with residues 120–140 in the C-terminal part of the protein. We provide evidence that SAP30L induces…

entsyymitvuorovaikutustumajyvänenBiologySAP30Protein Sorting SignalsHistone DeacetylasesArticleCell Line03 medical and health sciencesMice0302 clinical medicineHistone H1Histone H2AGeneticsHistone codeAnimalsHumansGene Silencingnucleolus030304 developmental biologyNuclear receptor co-repressor 2Histone deacetylationGenetics0303 health sciencesgeenitbiokemiaNuclear ProteinsCell biologyRepressor ProteinsProtein TransportSin3 Histone Deacetylase and Corepressor Complextranskriptio (biologia)030220 oncology & carcinogenesisSin-associated proteinsHistone deacetylase complexhistonideasetylaatioHistone deacetylaseproteiinitCorepressorSin-assosioituvat proteiinitCell NucleolusNucleic acids research
researchProduct

Regulación por estradiol de la producción de Angiotensina 1-7 y papel del receptor Mas en la producción de óxido nítrico en células endoteliales huma…

2017

El sistema renina-angiotensina intracelular (SRA) está formado por un conjunto de enzimas y metabolitos que se han relacionado con la regulación de la función cardiovascular y con la fisiopatología de la hipertensión arterial. El SRA clásico o circulante interviene en la regulación vascular principalmente con los péptidos bioactivos angiotensina (Ang) I y Ang II. La enzima que regula el paso de Ang I a Ang II es la enzima de conversión de la angiotensina 1 (ECA-1, la primera que se describió). En el año 2000 se descubrió que la enzima de conversión de la angiotensina 2 (ECA-2) convertía la Ang II en Ang 1-7. La Ang 1-7 es una molécula del SRA que tiene efecto fundamentalmente vasodilatador.…

enzima convertidora de angiotensinaestrógenoscélulas endotelialessistema renina angiotensinareceptores de estrógenos
researchProduct

Enzymatic systems involved in peri-receptor events of olfaction in mammalian: evolutionary perspectives

2021

International audience; The olfactory epithelium is continuously exposed to exogenous chemicals, including compounds bearing odor activity. Organisms have developed multiple mechanisms for the protection of this epithelium, among which anti-microbial proteins, enzymes fighting the oxidative stress and xenobiotic metabolizing enzymes. Our approach consists in characterizing by immunohistochemistry and mass spectroscopy analysis the proteome of the nasal mucus in different mammals (currently including Harbour porpoise, Homo sapiens, Mus musculus, Oryctolagus cuniculus, Rattus norvegicus). These analyses reveal core some enzyme families in the different species investigated, including glutathi…

enzymeevolution[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular Biology[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biologyolfactoryperi receptor events
researchProduct

MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation

2019

Mesenchymal stromal cells (hMSCs) display a pleiotropic function in bone regeneration. The signaling involved in osteoblast commitment is still not completely understood, and that determines the failure of current therapies being used. In our recent studies, we identified two miRNAs as regulators of hMSCs osteoblast differentiation driving hypoxia signaling and cytoskeletal reorganization. Other signalings involved in this process are epithelial to mesenchymal transition (EMT) and epidermal growth factor receptor (EGFR) signalings through the regulation of Yes-associated protein (YAP)/PDZ-binding motif (TAZ) expression. In the current study, we investigated the role of miR-33a family as a (…

epithelial mesenchymal transitionregenerative medicinePDZ DomainsCell CommunicationArticlemicroRNAmedicineHumansEpidermal growth factor receptorEpithelial–mesenchymal transitionBone regenerationCells CulturedEGFR inhibitorsAdaptor Proteins Signal TransducingOsteoblastsmicroRNAbiologyMesenchymal stem cellComputational BiologyOsteoblastMesenchymal Stem CellsYAP-Signaling ProteinsGeneral MedicinePhenotypeCell biologymicroRNAsErbB Receptorsmedicine.anatomical_structureTranscriptional Coactivator with PDZ-Binding Motif Proteinsmesenchymal stromal cellbiology.proteinTrans-Activatorsmesenchymal stromal cellsEGFR signalingSignal TransductionTranscription FactorsCells
researchProduct

Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies

2015

We have developed a highly versatile platform for the systematic retrieval of T-cell receptors (TCRs) from single-antigen-reactive T cells and for characterization of their function and specificity. This approach enables rapid extraction of multiple TCRs from repertoires in individuals and not only broadens the diversity of TCRs suitable for clinical use, but also sets the stage for actively personalized immunotherapeutic strategies.

epitopeAdoptive cell transferImmunologyT-cell receptorhemic and immune systemschemical and pharmacologic phenomenaComputational biologyBiologypersonalized immunotherapybiological factorsEpitopeOncologyAntigen specificImmunologyImmunology and AllergyT cell engineeringT cell receptorAuthor's Viewtissuesadoptive cell transferOncoImmunology
researchProduct

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta…

2017

Mounting evidence suggests that aberrations in immune-inflammatory pathways contribute to the pathophysiology of major depressive disorder (MDD), and individuals with MDD may have elevated levels of predominantly pro-inflammatory cytokines and C-reactive protein. In addition, previous meta-analyses suggest that antidepressant drug treatment may decrease peripheral levels of interleukin-1 beta (IL-1β) and IL-6. Recently, several new studies examining the effect of antidepressants on these cytokines have been published, and so we performed an updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD. The P…

epressionChemokinemedicine.drug_classmedicine.medical_treatmentNeuroscience (miscellaneous)InflammationAntidepressantPharmacology03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineHumansMeta-analysiCytokineInflammationDepressive Disorder MajorbiologyDepressionbusiness.industrymedicine.diseaseReceptor antagonistAntidepressive Agents030227 psychiatryMeta-analysisCytokineTreatment OutcomeAntidepressant; Chemokines; Cytokines; Depression; Inflammation; Meta-analysis; Cellular and Molecular NeuroscienceNeurologyChemokineMeta-analysisbiology.proteinCytokinesMajor depressive disorderAntidepressantTumor necrosis factor alphamedicine.symptomChemokinesbusiness030217 neurology & neurosurgeryMolecular neurobiology
researchProduct